Council Regulation (EC) No 129/2007 of 12 February 2007 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an international non-proprietary name (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87

As from 1 January 2007 the Community shall extend duty-free treatment to the INNs listed in Annex I.

As from 1 January 2007 the list of prefixes and suffixes which, in combination with the INNs, describe the salts, esters or hydrates of INNs which are also eligible for duty-free treatment, on condition that they are classifiable in the same six-digit HS-subheading as the corresponding INN, shall be replaced by the list in Annex II.

As from 1 January 2007 the Community shall extend duty-free treatment to the intermediates used in the production and manufacture of pharmaceutical products listed in Annex III.

As from 1 January 2007 the intermediates listed in Annex IV shall no longer benefit from duty-free treatment.

Annexes 3, 4 and 6 of Section II of Part three of Annex I to Regulation (EEC) No 2658/87 (Lists of pharmaceutical substances which qualify for duty-free treatment) shall be amended accordingly.

This Regulation shall enter into force on the day following its publication in the Official Journal of the European Union.